Related Experiment Video
Updated: Jul 20, 2025
08:55
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
9.5K
Oncolytic virotherapy in lung cancer
Estanislao Nistal-Villan1, Sergio Rius-Rocabert1, Francisco Llinares-Pinel2
1Microbiology Section, Departamento CC, Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Spain; Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
International Review of Cell and Molecular Biology
|August 4, 2023
Summary
Oncolytic virotherapy uses viruses to selectively destroy lung tumor cells and stimulate an immune response. Combining this with traditional therapies offers a promising strategy to improve lung cancer treatment and prevent relapse.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Lung tumors are aggressive and require improved treatments to combat relapse and metastasis.
- Current therapies offer survival benefits but have limitations.
- Immunotherapy stimulates the patient's immune system to fight cancer cells.
Purpose of the Study:
- To explore oncolytic virotherapy as a novel approach for lung cancer.
- To investigate the potential of viruses in selectively targeting and destroying cancer cells.
- To evaluate the combination of oncolytic virotherapy with traditional lung cancer treatments.
Main Methods:
- Utilizing viruses engineered to selectively infect and lyse cancer cells.
- Leveraging the immune system's response to viral infection for anti-tumor activity.
- Investigating the synergistic effects of combining oncolytic virotherapy with conventional therapies.
Main Results:
- Oncolytic viruses demonstrate selective tumor cell destruction.
- Viral infection triggers an immune response against tumor cells.
- Potential for enhanced cytotoxicity and long-term immune memory against cancer recurrence.
Conclusions:
- Oncolytic virotherapy is a promising strategy for lung cancer treatment.
- Combining oncolytic virotherapy with traditional therapies may overcome current challenges.
- Optimizing combination strategies and treatment parameters is the next frontier.
Related Concept Videos
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:30Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K